Studies are now ongoing to ascertain whether IBD-associated taurine deficiency is secondary to the mucosal inflammation-driven consumption of the molecule, as well as to assess the gene expression and enzymatic activity of cysteine sulfinic acid decarboxylase in IBD. The gene discussed is CSAD; the disease is inflammatory bowel disease.